Genmab A/S | 2,660.00 / +2.03% |
Date/Time | 08/19 / 16:54 |
Chg. / Chg.(%) | 53.00 / +2.03% |
Bid | - |
Ask | - |
Open | 2,611.00 |
Previous Close | 2,607.00 |
High | 2,669.00 |
Low | 2,611.00 |
Volume [DKK] | 37,066,198.50 |
Volume [Units] | 32,621 |
Price fixings | 2372 |
ISIN | DK0010272202 |
Security | GMAB/C |
Exchange | Cboe Europe DXE |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
OMX Nordic | 2,669.00 | ![]() |
100,164 |
Cboe Europe .. | 2,660.00 | ![]() |
32,621 |
London Inter.. | 2,656.0 | ![]() |
9,847 |
Turquoise | 2,659.00 | ![]() |
4,868 |
Nasdaq Other.. | 356.1000 | ![]() |
294 |
TradeGate | 356.700 | ![]() |
59 |
Cboe Europe .. | 2,652.50 | ![]() |
41 |
Frankfurt | 358.5000 | ![]() |
4 |
Vienna Globa.. | 358.50 | ![]() |
0 |
München | 353.20 | ![]() |
0 |
Düsseldorf | 357.60 | ![]() |
0 |
Hannover | 353.10 | ![]() |
0 |
Berlin | 358.00 | ![]() |
0 |
Stuttgart | 355.300 | ![]() |
0 |
Quotrix | 354.0000 | ![]() |
|
Lang & Schwa.. | 356.60 | ![]() |
|
gettex | 357.000 | ![]() |
|
Cboe Europe .. | 2,668.00 | 2 |
News
- Pfizer and BioNTech Submit for U.S. Emergency Use Authorization of an Additional Booster Dose of their COVID-19 Vaccine for Older Adults
03/15/2022 / 23:00 - GlobeNewswire - BioNTech and Regeneron Expand Strategic Collaboration to Advance Clinical Development of FixVac and Libtayo® (cemiplimab) Combination in NSCLC
03/08/2022 / 14:27 - GlobeNewswire - Notice to Convene the Annual General Meeting of Genmab A/S
02/24/2022 / 12:01 - GlobeNewswire - PTA-News: Medigene AG: BioNTech and Medigene announce global collaboration to advance T cell receptor immunotherapies against cancer
02/21/2022 / 19:25 - pressetext - BioNTech and Medigene Announce Global Collaboration to Advance T Cell Receptor Immunotherapies Against Cancer
02/21/2022 / 19:25 - GlobeNewswire